News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
425,181 Results
Type
Article (16492)
Company Profile (94)
Press Release (408595)
Multimedia
Podcasts (16)
Webinars (7)
Section
Business (132005)
Career Advice (901)
Deals (22644)
Drug Delivery (41)
Drug Development (50781)
Employer Resources (77)
FDA (9398)
Job Trends (9235)
News (214423)
Policy (15692)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (2)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (3)
2026 BioCapital Standard (1)
2026 Pharm Country Premier (1)
Academia (1507)
Accelerated approval (3)
Adcomms (10)
Allergies (43)
Alliances (31873)
ALS (72)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (109)
Approvals (9449)
Artificial intelligence (211)
Autoimmune disease (18)
Automation (11)
Bankruptcy (168)
Best Places to Work (7930)
BIOSECURE Act (7)
Biosimilars (42)
Biotechnology (78)
Bladder cancer (53)
Brain cancer (20)
Breast cancer (235)
Cancer (1866)
Cardiovascular disease (106)
Career advice (781)
Career pathing (11)
CAR-T (114)
Cell therapy (360)
Cervical cancer (17)
Clinical research (42319)
Collaboration (724)
Compensation (317)
Complete response letters (13)
COVID-19 (1141)
CRISPR (28)
C-suite (215)
Cystic fibrosis (71)
Data (1643)
Decentralized trials (1)
Denatured (5)
Depression (23)
Diabetes (168)
Diagnostics (4347)
Digital health (14)
Diversity (1)
Diversity, equity & inclusion (26)
Drug discovery (84)
Drug pricing (20)
Drug shortages (5)
Duchenne muscular dystrophy (49)
Earnings (55076)
Editorial (7)
Employer branding (11)
Employer resources (71)
Events (69226)
Executive appointments (633)
FDA (10315)
Featured Employer (26)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (659)
Gene editing (80)
Generative AI (18)
Gene therapy (205)
GLP-1 (341)
Government (1786)
Grass and pollen (1)
Guidances (37)
Healthcare (12273)
Huntington's disease (13)
IgA nephropathy (14)
Immunology and inflammation (65)
Indications (24)
Infectious disease (1228)
Inflammatory bowel disease (103)
Inflation Reduction Act (3)
Influenza (36)
Intellectual property (71)
Interviews (130)
IPO (11236)
IRA (7)
Job creations (1711)
Job search strategy (692)
Kidney cancer (11)
Labor market (7)
Layoffs (217)
Leadership (12)
Legal (3303)
Liver cancer (60)
Lung cancer (289)
Lymphoma (110)
Machine learning (4)
Management (28)
Manufacturing (206)
MASH (56)
Medical device (8625)
Medtech (8629)
Mergers & acquisitions (11846)
Metabolic disorders (403)
Multiple sclerosis (37)
NASH (14)
Neurodegenerative disease (55)
Neuropsychiatric disorders (11)
Neuroscience (1213)
NextGen: Class of 2025 (3815)
Non-profit (2798)
Northern California (2059)
Now hiring (4)
Obesity (184)
Opinion (115)
Ovarian cancer (68)
Pain (59)
Pancreatic cancer (70)
Parkinson's disease (120)
Partnered (16)
Patents (144)
Patient recruitment (84)
Peanut (20)
People (40053)
Pharmaceutical (17)
Pharmacy benefit managers (5)
Phase I (14136)
Phase II (18659)
Phase III (13791)
Pipeline (987)
Policy (40)
Postmarket research (1200)
Preclinical (5152)
Press Release (69)
Prostate cancer (85)
Psychedelics (13)
Radiopharmaceuticals (223)
Rare diseases (265)
Real estate (3234)
Recruiting (23)
Regulatory (11895)
Reports (20)
Research institute (1473)
Resumes & cover letters (111)
Rett syndrome (4)
RNA editing (4)
RSV (22)
Schizophrenia (42)
Series A (122)
Series B (79)
Service/supplier (4)
Sickle cell disease (36)
Southern California (1708)
Special edition (3)
Spinal muscular atrophy (83)
Sponsored (18)
Startups (2272)
State (1)
Stomach cancer (12)
Supply chain (36)
Tariffs (6)
The Weekly (11)
United States (17082)
Vaccines (289)
Venture capitalists (23)
Weight loss (88)
Women's health (20)
Worklife (4)
Date
Today (140)
Last 7 days (400)
Last 30 days (1907)
Last 365 days (25206)
2025 (7594)
2024 (26539)
2023 (29439)
2022 (38114)
2021 (39904)
2020 (36578)
2019 (28988)
2018 (21579)
2017 (20460)
2016 (18615)
2015 (22448)
2014 (16610)
2013 (13293)
2012 (14028)
2011 (14522)
2010 (13628)
Location
Africa (360)
Alabama (44)
Alaska (5)
Arizona (109)
Arkansas (10)
Asia (23584)
Australia (3542)
California (4587)
Canada (1482)
China (398)
Colorado (182)
Connecticut (241)
Delaware (93)
Europe (50083)
Florida (686)
Georgia (131)
Idaho (36)
Illinois (351)
India (16)
Indiana (233)
Iowa (8)
Japan (131)
Kansas (80)
Kentucky (21)
Louisiana (10)
Maine (67)
Maryland (622)
Massachusetts (3444)
Michigan (174)
Minnesota (231)
Mississippi (2)
Missouri (69)
Montana (22)
Nebraska (20)
Nevada (44)
New Hampshire (38)
New Jersey (1237)
New Mexico (24)
New York (1267)
North Carolina (800)
North Dakota (8)
Northern California (2059)
Ohio (153)
Oklahoma (11)
Oregon (16)
Pennsylvania (1023)
Puerto Rico (7)
Rhode Island (23)
South America (522)
South Carolina (18)
South Dakota (1)
Southern California (1708)
Tennessee (73)
Texas (658)
Utah (134)
Virginia (108)
Washington D.C. (35)
Washington State (421)
West Virginia (3)
Wisconsin (49)
425,181 Results for "advanced bionutrition corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Corporate Update: Psyence Biomedical Ltd Redefines Psychedelic Medicine with a Multi-Asset Strategy, Advancing Clinical Trials and Scalable Manufacturing
Company executives will host a corporate webinar for investors and stakeholders on Thursday, April 10, 2025
March 31, 2025
·
12 min read
Press Releases
Newleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth
April 8, 2025
·
3 min read
Press Releases
Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate
January 9, 2025
·
6 min read
Kintara Therapeutics and TuHURA Biosciences Provide Update on Recent Corporate and Clinical Advancements and Outline Near Term Milestones
Kintara Therapeutics, Inc. and TuHURA Biosciences, Inc. provided an overview of Kintara’s and TuHURA’s recent corporate and clinical advancements and outlined upcoming expected near term milestones.
July 1, 2024
·
12 min read
Layoffs
ImmunityBio Continues Trimming Workforce While Working to Advance Anktiva
ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to advance Anktiva in non-small cell lung cancer.
January 31, 2025
·
1 min read
·
Angela Gabriel
Business
Sengenics Corporation Announces New Collaboration to Advance Cancer Treatment
Sengenics Corporation LLC and Duke Health today announced an ambitious collaboration to redefine metastatic colorectal cancer (mCRC) treatment.
June 3, 2024
·
4 min read
Press Releases
IBL International collaborates with Grifols on advanced biomarker panels
April 9, 2025
·
3 min read
Press Releases
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
December 13, 2024
·
5 min read
Press Releases
Rigaku and SPERA PHARMA Initiate Strategic Partnership to Advanced Pharmaceutical Development
April 18, 2025
·
3 min read
Press Releases
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
November 19, 2024
·
8 min read
1 of 42,519
Next
